From Concept to Cure: The Road Ahead for Ruthenium‐Based Anticancer Drugs
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400435 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, 2024. Verfasst von Srividya Swaminathan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Computational Modelling, Chennai Institute of Technology, Chennai, Tamil Nadu, 600069, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ruthenium, Neoplasms, Coordination Complexes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Center for Computational Modeling at Chennai Institute of Technology (CIT), DST-INSPIRE, University of Atacama.
Abstract (Originalsprache)
The evolution of chemotherapy, especially the dawn of metal‐based drugs, represents a transformative era in cancer treatment. From the serendipitous discovery of mustard gas's cytotoxic effects to the sophisticated development of targeted therapies, chemotherapy has significantly refined. Central to this progression is the incorporation of metal‐based compounds, such as platinum (Pt), ruthenium (Ru), and gold (Au), which offer unique mechanisms of action, distinguishing them from organic therapeutics. Among these, Ru complexes, exemplified by BOLD‐100 and TLD1433, have shown exceptional promise due to their selective activity, lower propensity for resistance, and the ability to target spescific cellular pathways. This paper explores the journey of such Ru candidates, focusing on the mechanisms, efficacy, and clinical potential of these Ru‐based drugs, which stand at the forefront of current research, aiming to provide more targeted, less toxic, and highly effective cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Computational Modelling, Chennai Institute of Technology, Chennai, Tamil Nadu, 600069, India.
- Inorganic and Physical Chemistry Laboratory, CSIR-CLRI, Chennai, Tamil Nadu, 600020, India.
- Faculty of Medicine, University of Atacama, Los Carreras 1579, Copiapo, 1532502, Chile.
- Department of Chemistry, National Institute of Technology, Tiruchirappalli, Tamil Nadu, 620015, India.
ORCID-Profile: Srividya Swaminathan, Jebiti Haribabu, Ramasamy Karvembu
Förderung
- Center for Computational Modeling at Chennai Institute of Technology (CIT)
- DST-INSPIRE
- University of Atacama
- DST-SERB
- Universidad de Atacama
Zitieren
APA
Swaminathan, S., Haribabu, J., & Karvembu, R. (2024). From Concept to Cure: The Road Ahead for Ruthenium‐Based Anticancer Drugs. ChemMedChem. https://doi.org/10.1002/cmdc.202400435
Vancouver
Swaminathan S, Haribabu J, Karvembu R. From Concept to Cure: The Road Ahead for Ruthenium‐Based Anticancer Drugs. ChemMedChem. 2024. doi:10.1002/cmdc.202400435
BibTeX
@article{Swaminathan2024,
author = {Swaminathan, Srividya and Haribabu, Jebiti and Karvembu, Ramasamy},
title = {From Concept to Cure: The Road Ahead for Ruthenium‐Based Anticancer Drugs},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400435}
}
EUVIMED